FDA approval for targeted therapy in metastatic pancreatic cancer
FDA has approved a first-in-class targeted therapy for metastatic pancreatic cancer, per TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.